000 -LEADER |
fixed length control field |
00508nam a2200205Ia 4500 |
005 - DATE AND TIME OF LATEST TRANSACTION |
control field |
20221129100110.0 |
008 - FIXED-LENGTH DATA ELEMENTS--GENERAL INFORMATION |
fixed length control field |
180712s9999 xx 000 0 und d |
020 ## - INTERNATIONAL STANDARD BOOK NUMBER |
International Standard Book Number |
853699620 |
082 ## - DEWEY DECIMAL CLASSIFICATION NUMBER |
Classification number |
615.1342 |
Author Mark |
BRI |
DDC Edition number |
23 |
100 ## - MAIN ENTRY--PERSONAL NAME |
Personal name |
British National Formulary |
245 ## - TITLE STATEMENT |
Title |
BNF 61 March 2011 / |
260 ## - PUBLICATION, DISTRIBUTION, ETC. |
Place of publication, distribution, etc. |
London |
Name of publisher, distributor, etc. |
BMJ Group |
Date of publication, distribution, etc. |
2011 |
300 ## - PHYSICAL DESCRIPTION |
Extent |
xviii, 1036 p. |
500 ## - GENERAL NOTE |
General note |
Includes appendices and index |
650 ## - SUBJECT ADDED ENTRY--TOPICAL TERM |
Topical term or geographic name entry element |
BNF |
650 #4 - SUBJECT ADDED ENTRY--TOPICAL TERM |
Topical term or geographic name entry element |
Formulary |
9 (RLIN) |
7351 |
650 #4 - SUBJECT ADDED ENTRY--TOPICAL TERM |
Topical term or geographic name entry element |
Drugs |
9 (RLIN) |
5054 |
942 ## - ADDED ENTRY ELEMENTS (KOHA) |
item type |
Books in Reference (R) |